Calcium-Dependent Ion Channel Pharmacology
Creative Biolabs supports functional screening of calcium-activated ion channels for modulator discovery, hit confirmation, subtype selectivity, and mechanism-oriented studies. Assay plans can combine defined channel models with automated or manual patch clamp, scalable fluorescence or ion-flux readouts, concentration-response analysis, and orthogonal confirmation.
Discuss Your Channel TargetScientific Rationale
Calcium-activated channels convert changes in intracellular Ca2+ into electrical or ionic responses. In this group, calcium is the gating signal rather than necessarily the ion carried through the pore. Calcium-activated potassium channels can hyperpolarize the membrane and reshape excitability, while calcium-activated chloride channels can generate context-dependent anion currents. These differences make target identity, calcium control, voltage, ion gradients, and cell background central to assay design.
For BK channels, both intracellular calcium and membrane voltage influence opening, and auxiliary subunits can substantially shift gating and pharmacology. SK and KCa3.1 channels are strongly coupled to calcium/calmodulin signaling, whereas ANO1/TMEM16A and related CaCC targets require readouts that can distinguish direct chloride-channel modulation from compounds that alter upstream calcium signaling.
A practical project can therefore progress from a scalable primary assay to direct electrophysiological confirmation. For broader program context, explore our ion channel screening services, ligand-gated channel screening, and potassium channel screening service.
Target Coverage
Projects can focus on a defined target or compare related channel families. Species, isoform, accessory subunits, and model availability are confirmed during project design.
KCNMA1 · large-conductance Ca2+- and voltage-activated K+ channel
Useful for direct current assays that resolve calcium dependence, voltage dependence, activation, inhibition, and the impact of defined beta or gamma auxiliary subunits when required.
KCNN1, KCNN2, KCNN3 · small-conductance Ca2+-activated K+ channels
Well suited to controlled intracellular-calcium electrophysiology, subtype comparison, concentration-response testing, and selectivity studies against other KCa channels.
KCNN4 · intermediate-conductance Ca2+-activated K+ channel
Supports activator or inhibitor profiling with direct current measurements or scalable functional formats, depending on the model, throughput requirement, and decision point.
TMEM16A, TMEM16B · calcium-activated chloride channels
Can be addressed with direct electrophysiology or anion-sensitive functional readouts, with controls designed to separate direct channel activity from upstream changes in intracellular calcium.
| Channel Family | Key Gating Variables | Useful Readouts | Typical Screening Questions |
|---|---|---|---|
| BK / KCa1.1 | Free intracellular Ca2+, membrane voltage, auxiliary subunits | Automated or manual patch clamp; selected optical formats | Activator/inhibitor potency, gating shifts, auxiliary-subunit effects |
| SK / KCa2.x | Intracellular Ca2+, calmodulin coupling, subtype | Automated patch clamp; concentration-response analysis | Subtype potency, selectivity, direct current inhibition or activation |
| KCa3.1 | Intracellular Ca2+, cell background, reference pharmacology | Patch clamp; scalable functional screening | Hit discovery, confirmation, cross-family selectivity |
| ANO1 / ANO2 | Intracellular Ca2+, voltage, chloride gradient, stimulation route | Patch clamp; chloride/halide-sensitive fluorescence or flux | Direct CaCC modulation, activator/inhibitor profiling, orthogonal confirmation |
Assay Platforms
The right platform depends on whether the study needs throughput, direct current measurement, mechanistic resolution, or a staged combination of these goals.
Directly records channel current in a scalable electrophysiology format. Protocols can be optimized for calcium level, voltage steps or ramps, compound exposure, reference controls, and concentration-response testing.
Provides flexible control over intracellular and extracellular solutions and supports detailed follow-up on gating, kinetics, voltage dependence, calcium dependence, and mechanistic questions.
Membrane-potential, ion-sensitive, or halide-sensitive readouts can provide a practical route for larger compound sets when the target biology and assay window support an optical format.
Assay planning considers species, gene or isoform, accessory subunits, expression level, parental background, and model stability. Off-the-shelf or tailored channel cell models can be evaluated according to project needs.
Primary-screen actives can be retested across concentration ranges and confirmed by a direct current assay or an independent functional readout. Parental-cell and related-channel controls can help identify indirect or nonspecific effects.
Support can include trace review, normalization, plate or cell quality checks, concentration-response fitting, potency estimates, subtype comparisons, graphical summaries, and interpretation within the selected assay context.
Need a high-throughput primary screen, a direct electrophysiology assay, or both? Start with the biological decision and define the minimum readout needed to make it confidently.
Explore Screening TechnologiesScreening Strategy
Each project can be scaled to the compound set and the level of mechanistic confidence required.
Confirm channel family, species, isoform, auxiliary subunits, cell background, and the decision the assay must support.
Establish expression and a reproducible functional window using appropriate calcium conditions, stimulation, and reference modulators.
Apply the selected optical or electrophysiological format with agreed controls, concentration scheme, and acceptance criteria.
Retest hits, generate concentration-response curves, and use direct current or orthogonal controls to remove artifacts.
Compare relevant subtypes or related channels and package traces, potency analysis, QC context, and study conclusions.
Applications
A calcium-activated channel assay can be designed around discovery, confirmation, selectivity, or a focused mechanistic question rather than a one-size-fits-all endpoint.
Screen compound sets for functional enhancement or inhibition under target-appropriate calcium and stimulation conditions.
Retest primary actives, establish concentration-response behavior, and verify direct channel modulation with an orthogonal readout where useful.
Compare related KCa or CaCC targets, auxiliary-subunit contexts, or counter targets to understand the selectivity profile of a candidate.
Use channel-level pharmacology to support studies of afterhyperpolarization, membrane excitability, firing behavior, neurotransmission, and other calcium-coupled processes.
Assay Design Considerations
Define free intracellular Ca2+ or the calcium-stimulation route so target activation is reproducible and interpretable.
Specify isoform and auxiliary subunits where they are expected to alter gating, expression, or compound pharmacology.
Match voltage protocols and K+ or Cl- gradients to the channel family and the pharmacological behavior being measured.
Use reference modulators, parental cells, orthogonal assays, or related channels to distinguish target activity from indirect effects.
Related Research
These open-access studies illustrate how direct electrophysiology and fluorescence-based functional measurements can support calcium-activated channel pharmacology.
Simó-Vicens and colleagues used stable HEK293 lines expressing human SK1, SK2, or SK3 and a QPatch automated patch-clamp platform to characterize the inhibitor BBP. The study controlled intracellular free calcium and generated concentration-dependent inhibition curves, illustrating how direct current recording can support subtype potency and selectivity analysis for calcium-activated potassium channels.
Simó-Vicens R, Bomholtz SH, Sørensen US, Bentzen BH. "2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels." Frontiers in Pharmacology. 2018;9:1409. DOI: 10.3389/fphar.2018.01409
Seo and colleagues screened a compound collection in FRT cells stably expressing human ANO1/TMEM16A together with a halide-sensitive YFP reporter, then characterized active compounds with current measurements and whole-cell patch clamp. The study illustrates a practical CaCC cascade in which scalable fluorescence identifies candidate modulators and electrophysiology helps confirm direct channel activity and selectivity.
Seo Y, Park J, Kim M, Lee HK, Kim J-H, Jeong J-H, et al. "Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines." PLOS ONE. 2015;10(7):e0133656. DOI: 10.1371/journal.pone.0133656
FAQ
Bring the target, construct context, compound set, and decision criteria. We will help map them to a practical model, calcium condition, and readout strategy.
Fill out the form below, and our expert team will contact you to design your custom project and accelerate breakthrough innovations.
